New Devices and Emerging Therapies

Moderators: Gerhard Scheuch (Activaero, Gemunden, Germany) and Rajiv Dhand (University of Tennessee)

Performance Testing of a Novel Continuous Powder Aerosolizer (CPA) for Inhalative Administration of Surfactant to Preterm Neonates

O Helwich¹, W Koch¹, P Iwatschenko², H Windt¹, FJH Taut³, C De Muynck⁴, and G Pohlmann¹

¹Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany
²MTF MediTech Franken GmbH, Eckental, Germany
³Takeda Pharmaceuticals Int’l, Zürich, Switzerland
⁴Nycomed: a Takeda Company, Konstanz, Germany

Feasibility Testing of Low Molecular Weight Heparin (LMWH): Loaded Large Porous PEG-PLGA Microparticles for the Treatment of Asthma

B Patel, N Gupta and F Ahsan

Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX, United States of America

Bioengineering of siRNA for Treatment of Inflammatory Lung Disease

JM Ramsey¹, C Kelly², AB Yadav¹, NG McElvaney⁴, D Small³, C Taggart³, and SA Cryan¹

¹ School of Pharmacy, Royal College of Surgeons in Ireland, Dublin 2, Ireland
² School of Biology and Environment Science, University College Dublin, Dublin 4, Ireland
³ Centre for Infection and Immunity, Queen’s University Belfast, Belfast, United Kingdom
⁴ Respiratory Research Division, RCSI, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland

Efficacy of Inhaled Liposome-Encapsulated Ciprofloxacin against Yersinia Pestis

KA Hamblin¹, JD Blanchard², C Davies¹, SV Harding¹, and AJH Simpson¹

¹ Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire, United Kingdom
² Aradigm Corporation, Hayward, CA, United States of America